Intrapleural bortezomib for the therapy of myelomatous pleural effusion: a case report

Case Reports Immunol. 2012:2012:978479. doi: 10.1155/2012/978479. Epub 2012 Oct 11.

Abstract

Myelomatous pleural effusion (MPE) is an extremely rare manifestation of multiple myeloma (MM). We present a case of MPE in a patient with IgG-κ MM treated with intrapleural bortezomib with systemic bortezomib-based therapy. Although we observed good local response, the patient succumbed due to systemic myeloma progression.